Connor, Clark & Lunn Investment Management (CC&L)
ENZN

Connor, Clark & Lunn Investment Management (CC&L)’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-572,321
Closed -$269K – 997
2016
Q1 		$269K Hold
572,321
– – ﹤0.01% 671
2015
Q4 		$389K Buy
572,321
+23,800
+4% +$18.9K ﹤0.01% 588
2015
Q3 		$532K Buy
548,521
+191,200
+54% +$235K ﹤0.01% 509
2015
Q2 		$429K Buy
357,321
+94,800
+36% +$121K ﹤0.01% 447
2015
Q1 		$278K Buy
262,521
+32,200
+14% +$33.3K ﹤0.01% 466
2014
Q4 		$251K Buy
230,321
+9,300
+4% +$9.76K ﹤0.01% 494
2014
Q3 		$239K Hold
221,021
– – ﹤0.01% 472
2014
Q2 		$245K Sell
221,021
-4,737
-2% -$4.51K ﹤0.01% 471
2014
Q1 		$257K Buy
225,758
+34,700
+18% +$35.8K ﹤0.01% 588
2013
Q4 		$235K Buy
191,058
+9,487
+5% +$14.6K ﹤0.01% 644
2013
Q3 		$314K Buy
181,571
+41,734
+30% +$77.2K ﹤0.01% 415
2013
Q2 		$295K Buy
+139,837
New +$409K ﹤0.01% 428

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ENZN Position: Q2 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 572,321 shares — an estimated $269K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $532K in Q3 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 572,321 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $269K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ENZON PHARMACEUTICALS INC position peaked at $532K in Q3 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2016, filed 15 Aug 2016.